Article preview from IN VIVO January 27, 2009
With the traditional pharmaceutical commercial model in disarray, companies are looking for new approaches to maintaining their competitive position. Read on...
Article preview from IN VIVO January 27, 2009
ith the traditional pharmaceutical commercial model in disarray, companies are looking for new approaches to maintaining their competitive position.
They're talking about--and in some cases implementing--"new commercial models," which rely heavily on reorganizing sales and marketing organizations by region, decreasing emphasis on one-on-one physician relationships, and paying more attention to building business-to-business relationships with diverse stakeholders, notably payors-including public and private payors and employers--and patient advocacy groups.
Read the rest of this 3633-word article by purchasing it now for $125.
